L-Lysine: What the Cold Sore Evidence Actually Shows

By Erin Rose · Updated July 20, 2026 · Methodology

Educational overview — not medical advice. Lysine is not a treatment for an active cold sore and not a substitute for antiviral medication; the cold-sore-prevention evidence below is genuinely mixed, not proven. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

As an Amazon Associate we earn from qualifying purchases. Ranked by cost at the trial-relevant dose, never commissions.

Start here

What lysine is (and what it actually does in the body)

L-lysine is one of the nine essential amino acids — your body can't make it, so it comes from protein-containing food (meat, dairy, legumes) or a supplement. Beyond the cold-sore question, lysine is a genuine building block for collagen synthesis (see our collagen guide for the skin/joint evidence on that front) and general protein turnover. The reason it shows up specifically in cold-sore discussions is a proposed mechanism: lysine structurally resembles arginine, another amino acid that herpes simplex virus (HSV) needs to replicate, and in tissue-culture experiments lysine antagonized arginine's virus-growth-promoting effect (Griffith 1981). That's real biology — but it's a cell-culture finding, not proof that taking lysine changes what happens in an actual person's skin.

Does it work? (the honest short version)

Split roughly down the middle. Three double-blind, placebo-controlled RCTs found a benefit at sustained higher doses: Griffith 1987 (n=52, 3,000 mg/day for 6 months) found significantly fewer, milder, and faster-healing recurrences; McCune 1984 (n=41) found 1,248 mg/day reduced recurrence rate while a lower 624 mg/day dose did not — a clean dose-floor result; Thein & Hurt 1984 (n=26) found fewer lesions, with the effect tracking a serum lysine threshold rather than the label dose alone. But three other double-blind RCTs found essentially nothing: Milman 1980, the largest trial in this set (n=65, 1,000 mg/day), found "no effect on the recurrence rate" as its primary result (though a secondary measure — more patients staying recurrence-free on lysine than placebo — reached borderline significance, p=0.05); DiGiovanna & Blank 1984 (n=21, 1,200 mg/day) concluded it's "unlikely that lysine improves" recurrent HSV; and Simon 1985 (no abstract available; cited by title/design only) also reached a null conclusion. The 2015 Cochrane review of cold-sore prevention interventions placed lysine among those that "either showed no efficacy or could not confirm their efficacy," a different, weaker bucket than oral antivirals, which Cochrane found did reduce recurrence. See the full trial-by-trial breakdown.

The thinner thread: anxiety

A secondary use sometimes mentioned for lysine is anxiety reduction, based on two small human trials (Smriga 2007, n=108; Jezova 2005, a high-trait-anxiety subgroup) that found reduced anxiety and stress-hormone changes. The honest caveat is load-bearing: both trials dosed lysine together with an equal amount of arginine (about 2.6 g/day each), not lysine alone, so lysine's individual contribution to the effect is unconfirmed. This is a thin, confounded thread, not a standalone-lysine anxiety claim. If anxiety is your primary reason for supplementing, ashwagandha's anxiety evidence is better-supported and worth reading first.

Safety

Lysine is generally well tolerated at the doses studied here, including 3,000 mg/day for 6 months in Griffith 1987, with no notable adverse-effect signal reported across these trials. A few things to flag every time dosing is discussed: kidney disease caution — high-dose amino acid supplementation warrants a clinician's input in anyone with impaired kidney function, since the kidneys handle the added nitrogen/amino-acid load; mild GI upset is the most commonly reported side effect at higher doses; and lysine competes with arginine for absorption by design (that's the proposed HSV mechanism), a theoretical interaction note rather than a proven harm. Most importantly: lysine is not a treatment for an active cold sore and not a replacement for antiviral medication (acyclovir, valacyclovir, docosanol) — every positive trial here tested prevention over months, not clearing a sore that's already present. Pregnant or breastfeeding people should default to food-first intake and check with a clinician, as there's no dedicated supplement-safety trial data in this evidence set.

Frequently asked questions

Related guides

• Zinc — a common cold-sore combo ingredient, its own immune-support cluster
• Elderberry — another retail-adjacent immune-support supplement, honestly evidenced
• Vitamin C — commonly co-formulated with lysine in combo products
• Collagen — lysine's other real job, as a collagen-synthesis precursor amino acid
• Ashwagandha for Anxiety & Stress — the better-evidenced anxiety alternative

Sources